A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy

A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy

Background Few clinical studies compare the long-term remission, relapse, and safety of rituximab (RTX) or a combination of intermittent intravenous infusion of cyclophosphamide (CTX) and oral corticosteroid for primary membranous nephropathy (PMN) patients.Methods We collected multicenter retrospec...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Wang, Xiaoyan Ma, Xinyu Yang, Shoujun Bai, Xiujuan Zang, Lin Liao, Yakun Wang, Zexin Lv, Ting Zhang, Shougang Zhuang, Na Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Primary membranous nephropathy
rituximab
cyclophosphamide
remission
relapse
safety evaluation
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2409353
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2024.2409353

Similar Items